BLASTX nr result
ID: Glycyrrhiza30_contig00025285
seq
BLASTX 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Query= Glycyrrhiza30_contig00025285
(1163 letters)
Database: ./nr
115,041,592 sequences; 42,171,959,267 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
KRH69523.1 hypothetical protein GLYMA_02G033000, partial [Glycin... 530 e-180
XP_013461084.1 disease resistance protein (TIR-NBS-LRR class) [M... 536 e-175
XP_003517729.2 PREDICTED: disease resistance protein RML1A-like ... 512 e-166
XP_006573050.1 PREDICTED: disease resistance protein RML1A-like ... 512 e-166
XP_006593609.1 PREDICTED: putative disease resistance protein At... 466 e-154
XP_014620824.1 PREDICTED: putative disease resistance protein At... 466 e-154
KHN40240.1 TMV resistance protein N [Glycine soja] 466 e-153
XP_003543819.2 PREDICTED: TMV resistance protein N-like isoform ... 466 e-153
KRG89808.1 hypothetical protein GLYMA_20G048800 [Glycine max] KR... 444 e-148
KYP39886.1 Putative disease resistance protein At4g11170 family ... 449 e-146
KRG89798.1 hypothetical protein GLYMA_20G048800 [Glycine max] KR... 444 e-145
XP_006605620.1 PREDICTED: TMV resistance protein N-like isoform ... 444 e-145
XP_014519091.1 PREDICTED: TMV resistance protein N-like isoform ... 432 e-143
XP_006605619.1 PREDICTED: TMV resistance protein N-like isoform ... 444 e-143
KRG89797.1 hypothetical protein GLYMA_20G048800 [Glycine max] 444 e-143
XP_006605615.1 PREDICTED: TMV resistance protein N-like isoform ... 444 e-143
XP_013460028.1 disease resistance protein (TIR-NBS-LRR class) [M... 437 e-143
XP_013460038.1 disease resistance protein (TIR-NBS-LRR class) [M... 441 e-142
XP_004516106.1 PREDICTED: TMV resistance protein N-like isoform ... 441 e-142
XP_013460039.1 disease resistance protein (TIR-NBS-LRR class) [M... 441 e-142
>KRH69523.1 hypothetical protein GLYMA_02G033000, partial [Glycine max]
Length = 787
Score = 530 bits (1364), Expect = e-180
Identities = 260/367 (70%), Positives = 305/367 (83%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
K YDVFLSFRGEDTRGN TSHL+ AL+Q ++ETYIDYRL+KG+EIS ALI AIEES VSV
Sbjct: 23 KSYDVFLSFRGEDTRGNFTSHLYDALIQAKLETYIDYRLQKGEEISQALIEAIEESQVSV 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSE Y +SKWCLDE+ KI+ECK+ +GQVV+PVFYK+DPSH+RKQ+G + F H++D
Sbjct: 83 VIFSEKYGTSKWCLDEITKIMECKEGQGQVVIPVFYKIDPSHIRKQQGSFNKAFEEHKRD 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
N RV KWR ALT+AANLAGWDS+TY RTE++FIKDIVKD+L KL+LIYP+E KGL
Sbjct: 143 PNITNDRVQKWRSALTKAANLAGWDSITY--RTEAKFIKDIVKDVLYKLNLIYPIETKGL 200
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
+GIE NY +ESLLEIGSRE+R GKTTLAI+LHAKL SQFEGHCFL +VR
Sbjct: 201 IGIERNYAEIESLLEIGSREIRVIGIWGMGGIGKTTLAISLHAKLFSQFEGHCFLGNVRV 260
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
Q+EK GLN LR LFS L ENLHV +PKVESHF+TRRL+RKKVF++LDDVA+SEQLE
Sbjct: 261 QAEKHGLNALRRTLFSELFPGENLHVHVPKVESHFITRRLKRKKVFLILDDVASSEQLED 320
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D +C GPGSRV+VTTRD+HIFSHVD IYEVKELN HDSLQLFCLN+FR+ H +NG+E
Sbjct: 321 LIGDFNCFGPGSRVIVTTRDKHIFSHVDEIYEVKELNHHDSLQLFCLNAFREKHSKNGFE 380
Query: 22 ELSESAI 2
ELSES +
Sbjct: 381 ELSESVL 387
>XP_013461084.1 disease resistance protein (TIR-NBS-LRR class) [Medicago truncatula]
KEH35118.1 disease resistance protein (TIR-NBS-LRR class)
[Medicago truncatula]
Length = 1443
Score = 536 bits (1381), Expect = e-175
Identities = 274/372 (73%), Positives = 314/372 (84%), Gaps = 4/372 (1%)
Frame = -2
Query: 1105 PKKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVS 926
PKKYDVFLSFRGEDTR NITSHL AL QK+VETYIDYRLEKG+ I +LITAIEESHVS
Sbjct: 17 PKKYDVFLSFRGEDTRDNITSHLCEALNQKKVETYIDYRLEKGEGIGPSLITAIEESHVS 76
Query: 925 VVIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQ 746
VVIFSENYASSKWCLDE+ KI+ECKK+RGQ+V+PVFYK+DPSHVR QRG Y+ FA+HE
Sbjct: 77 VVIFSENYASSKWCLDEIVKIMECKKDRGQIVIPVFYKIDPSHVRNQRGTYKKWFAKHES 136
Query: 745 DL--NTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVEL 572
DL N+ +RV WR A+TEAANLAGWD TYR+ES+FIKDIVKDILQ+L+ + P+EL
Sbjct: 137 DLMSNSSQNRVFNWRSAVTEAANLAGWDF--QTYRSESQFIKDIVKDILQRLNFVQPIEL 194
Query: 571 KGLVGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLAS 392
KG+VGIEENY GV+SLLE+GS+EV+ GKTTLAIALHAKL SQFEGHCFLA+
Sbjct: 195 KGVVGIEENYEGVKSLLEMGSKEVKRIGIWGMGGIGKTTLAIALHAKLFSQFEGHCFLAN 254
Query: 391 VREQSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQ 212
VREQ+EK ++ LRNKLFS LLEEENLHVD+PKVE V RLRRKKV IVLD+VA SEQ
Sbjct: 255 VREQTEKNSIDFLRNKLFSELLEEENLHVDVPKVEYRHVNNRLRRKKVLIVLDNVANSEQ 314
Query: 211 LEGLISDSD--CLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHP 38
L+ LISDSD CLGPGSRV+VTTRD+HI S+VD IYEVKELNKH+SLQLFCL F++ HP
Sbjct: 315 LDDLISDSDYECLGPGSRVIVTTRDKHITSNVDEIYEVKELNKHNSLQLFCLTVFKEKHP 374
Query: 37 ENGYEELSESAI 2
++GYEELSES I
Sbjct: 375 KSGYEELSESVI 386
>XP_003517729.2 PREDICTED: disease resistance protein RML1A-like isoform X2 [Glycine
max] KRH74627.1 hypothetical protein GLYMA_01G032400
[Glycine max]
Length = 1452
Score = 512 bits (1319), Expect = e-166
Identities = 259/368 (70%), Positives = 303/368 (82%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
K+YDVFLSFRGEDTR ITSHL+ AL Q + TYIDYRL+KGDEIS ALI AIEES VSV
Sbjct: 20 KRYDVFLSFRGEDTRKIITSHLYHALFQAELATYIDYRLQKGDEISQALIEAIEESQVSV 79
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
+IFSE YA+SKWCLDE+ KI+ECK+ +GQVV+PVFYK+DPSH+RKQ+G ++ F HEQD
Sbjct: 80 IIFSEKYATSKWCLDEITKIIECKEGQGQVVIPVFYKIDPSHIRKQQGSFKQAFVEHEQD 139
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
L RV KWR ALT+AANLAGWD TYRTE+EFIKDIVKD+L KL+LIYP+ELKGL
Sbjct: 140 LKITTDRVQKWREALTKAANLAGWD--FQTYRTEAEFIKDIVKDVLLKLNLIYPIELKGL 197
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
+GIE NY +ESLL+I SR+VR GKTTLA AL+AKL S+FEGHCFL +VRE
Sbjct: 198 IGIEGNYTRIESLLKIDSRKVRVIGIWGMGGIGKTTLATALYAKLFSRFEGHCFLGNVRE 257
Query: 382 QSEKCGLNVLRNKLFSALLEEEN-LHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
Q+EK GL+ LR KLFS LL EN LH ++PKVE HF+TRRL+RKKVF+VLDDVA+SEQLE
Sbjct: 258 QAEKQGLDFLRTKLFSELLPGENHLHENMPKVEYHFITRRLKRKKVFLVLDDVASSEQLE 317
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D +C GPGSRV+VTTRD+HIFS+VD IYEVKELN DSLQLFCLN+FR+ HP+NG+
Sbjct: 318 DLIDDFNCFGPGSRVIVTTRDKHIFSYVDEIYEVKELNDLDSLQLFCLNAFREKHPKNGF 377
Query: 25 EELSESAI 2
EELSES I
Sbjct: 378 EELSESVI 385
>XP_006573050.1 PREDICTED: disease resistance protein RML1A-like isoform X1 [Glycine
max] KRH74626.1 hypothetical protein GLYMA_01G032400
[Glycine max]
Length = 1453
Score = 512 bits (1319), Expect = e-166
Identities = 259/368 (70%), Positives = 303/368 (82%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
K+YDVFLSFRGEDTR ITSHL+ AL Q + TYIDYRL+KGDEIS ALI AIEES VSV
Sbjct: 20 KRYDVFLSFRGEDTRKIITSHLYHALFQAELATYIDYRLQKGDEISQALIEAIEESQVSV 79
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
+IFSE YA+SKWCLDE+ KI+ECK+ +GQVV+PVFYK+DPSH+RKQ+G ++ F HEQD
Sbjct: 80 IIFSEKYATSKWCLDEITKIIECKEGQGQVVIPVFYKIDPSHIRKQQGSFKQAFVEHEQD 139
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
L RV KWR ALT+AANLAGWD TYRTE+EFIKDIVKD+L KL+LIYP+ELKGL
Sbjct: 140 LKITTDRVQKWREALTKAANLAGWD--FQTYRTEAEFIKDIVKDVLLKLNLIYPIELKGL 197
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
+GIE NY +ESLL+I SR+VR GKTTLA AL+AKL S+FEGHCFL +VRE
Sbjct: 198 IGIEGNYTRIESLLKIDSRKVRVIGIWGMGGIGKTTLATALYAKLFSRFEGHCFLGNVRE 257
Query: 382 QSEKCGLNVLRNKLFSALLEEEN-LHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
Q+EK GL+ LR KLFS LL EN LH ++PKVE HF+TRRL+RKKVF+VLDDVA+SEQLE
Sbjct: 258 QAEKQGLDFLRTKLFSELLPGENHLHENMPKVEYHFITRRLKRKKVFLVLDDVASSEQLE 317
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D +C GPGSRV+VTTRD+HIFS+VD IYEVKELN DSLQLFCLN+FR+ HP+NG+
Sbjct: 318 DLIDDFNCFGPGSRVIVTTRDKHIFSYVDEIYEVKELNDLDSLQLFCLNAFREKHPKNGF 377
Query: 25 EELSESAI 2
EELSES I
Sbjct: 378 EELSESVI 385
>XP_006593609.1 PREDICTED: putative disease resistance protein At4g11170 isoform X3
[Glycine max] KRH18686.1 hypothetical protein
GLYMA_13G076200 [Glycine max]
Length = 878
Score = 466 bits (1199), Expect = e-154
Identities = 250/368 (67%), Positives = 285/368 (77%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHL+ AL QK++ETYIDYRLEKGDEISAALI AIE+SHVSV
Sbjct: 27 KKYDVFLSFRGEDTRKNFTSHLYEALKQKKIETYIDYRLEKGDEISAALIKAIEDSHVSV 86
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E+ KI+ECKKERGQ+V+PVFY +DPSHVRKQ G YE FA+H
Sbjct: 87 VIFSENYASSKWCLGELGKIMECKKERGQIVIPVFYNIDPSHVRKQTGSYEQSFAKH--- 143
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
T R KW+ ALTEAANLA WDS YRTESEF+KDIVKD+L+KL YP K L
Sbjct: 144 --TGEPRCSKWKAALTEAANLAAWDS--QIYRTESEFLKDIVKDVLRKLAPRYPNHRKEL 199
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VG+EENY +ESLL+IGS +VR GKTTLA AL+ KLS +FEG CFLA+VRE
Sbjct: 200 VGVEENYEKIESLLKIGSSKVRILGIWGMGGIGKTTLASALYDKLSPEFEGCCFLANVRE 259
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPK-VESHFVTRRLRRKKVFIVLDDVATSEQLE 206
+S+K G LRNKLFS LLE ENL D + SHFV RL RKKVFIVLDDV TSEQLE
Sbjct: 260 ESDKHGFKALRNKLFSELLENENLCFDASSFLVSHFVLSRLGRKKVFIVLDDVDTSEQLE 319
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D D LG GSRV+VTTR++ IFS VD IY+VKEL+ H SL+LFCL+ FR+ P++GY
Sbjct: 320 NLIEDFDFLGLGSRVIVTTRNKQIFSQVDKIYKVKELSIHHSLKLFCLSVFREKQPKHGY 379
Query: 25 EELSESAI 2
E+LS SAI
Sbjct: 380 EDLSRSAI 387
>XP_014620824.1 PREDICTED: putative disease resistance protein At4g11170 isoform X2
[Glycine max]
Length = 909
Score = 466 bits (1199), Expect = e-154
Identities = 250/368 (67%), Positives = 285/368 (77%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHL+ AL QK++ETYIDYRLEKGDEISAALI AIE+SHVSV
Sbjct: 27 KKYDVFLSFRGEDTRKNFTSHLYEALKQKKIETYIDYRLEKGDEISAALIKAIEDSHVSV 86
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E+ KI+ECKKERGQ+V+PVFY +DPSHVRKQ G YE FA+H
Sbjct: 87 VIFSENYASSKWCLGELGKIMECKKERGQIVIPVFYNIDPSHVRKQTGSYEQSFAKH--- 143
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
T R KW+ ALTEAANLA WDS YRTESEF+KDIVKD+L+KL YP K L
Sbjct: 144 --TGEPRCSKWKAALTEAANLAAWDS--QIYRTESEFLKDIVKDVLRKLAPRYPNHRKEL 199
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VG+EENY +ESLL+IGS +VR GKTTLA AL+ KLS +FEG CFLA+VRE
Sbjct: 200 VGVEENYEKIESLLKIGSSKVRILGIWGMGGIGKTTLASALYDKLSPEFEGCCFLANVRE 259
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPK-VESHFVTRRLRRKKVFIVLDDVATSEQLE 206
+S+K G LRNKLFS LLE ENL D + SHFV RL RKKVFIVLDDV TSEQLE
Sbjct: 260 ESDKHGFKALRNKLFSELLENENLCFDASSFLVSHFVLSRLGRKKVFIVLDDVDTSEQLE 319
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D D LG GSRV+VTTR++ IFS VD IY+VKEL+ H SL+LFCL+ FR+ P++GY
Sbjct: 320 NLIEDFDFLGLGSRVIVTTRNKQIFSQVDKIYKVKELSIHHSLKLFCLSVFREKQPKHGY 379
Query: 25 EELSESAI 2
E+LS SAI
Sbjct: 380 EDLSRSAI 387
>KHN40240.1 TMV resistance protein N [Glycine soja]
Length = 970
Score = 466 bits (1199), Expect = e-153
Identities = 250/368 (67%), Positives = 285/368 (77%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHL+ AL QK++ETYIDYRLEKGDEISAALI AIE+SHVSV
Sbjct: 18 KKYDVFLSFRGEDTRKNFTSHLYEALKQKKIETYIDYRLEKGDEISAALIKAIEDSHVSV 77
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E+ KI+ECKKERGQ+V+PVFY +DPSHVRKQ G YE FA+H
Sbjct: 78 VIFSENYASSKWCLGELGKIMECKKERGQIVIPVFYNIDPSHVRKQTGSYEQSFAKH--- 134
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
T R KW+ ALTEAANLA WDS YRTESEF+KDIVKD+L+KL YP K L
Sbjct: 135 --TGEPRCSKWKAALTEAANLAAWDS--QIYRTESEFLKDIVKDVLRKLAPRYPNHRKEL 190
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VG+EENY +ESLL+IGS +VR GKTTLA AL+ KLS +FEG CFLA+VRE
Sbjct: 191 VGVEENYEKIESLLKIGSSKVRILGIWGMGGIGKTTLASALYDKLSPEFEGCCFLANVRE 250
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPK-VESHFVTRRLRRKKVFIVLDDVATSEQLE 206
+S+K G LRNKLFS LLE ENL D + SHFV RL RKKVFIVLDDV TSEQLE
Sbjct: 251 ESDKHGFKALRNKLFSELLENENLCFDASSFLVSHFVLSRLGRKKVFIVLDDVDTSEQLE 310
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D D LG GSRV+VTTR++ IFS VD IY+VKEL+ H SL+LFCL+ FR+ P++GY
Sbjct: 311 NLIEDFDFLGLGSRVIVTTRNKQIFSQVDKIYKVKELSIHHSLKLFCLSVFREKQPKHGY 370
Query: 25 EELSESAI 2
E+LS SAI
Sbjct: 371 EDLSRSAI 378
>XP_003543819.2 PREDICTED: TMV resistance protein N-like isoform X1 [Glycine max]
XP_014620822.1 PREDICTED: TMV resistance protein N-like
isoform X1 [Glycine max] XP_014620823.1 PREDICTED: TMV
resistance protein N-like isoform X1 [Glycine max]
KRH18685.1 hypothetical protein GLYMA_13G076200 [Glycine
max]
Length = 979
Score = 466 bits (1199), Expect = e-153
Identities = 250/368 (67%), Positives = 285/368 (77%), Gaps = 1/368 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHL+ AL QK++ETYIDYRLEKGDEISAALI AIE+SHVSV
Sbjct: 27 KKYDVFLSFRGEDTRKNFTSHLYEALKQKKIETYIDYRLEKGDEISAALIKAIEDSHVSV 86
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E+ KI+ECKKERGQ+V+PVFY +DPSHVRKQ G YE FA+H
Sbjct: 87 VIFSENYASSKWCLGELGKIMECKKERGQIVIPVFYNIDPSHVRKQTGSYEQSFAKH--- 143
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
T R KW+ ALTEAANLA WDS YRTESEF+KDIVKD+L+KL YP K L
Sbjct: 144 --TGEPRCSKWKAALTEAANLAAWDS--QIYRTESEFLKDIVKDVLRKLAPRYPNHRKEL 199
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VG+EENY +ESLL+IGS +VR GKTTLA AL+ KLS +FEG CFLA+VRE
Sbjct: 200 VGVEENYEKIESLLKIGSSKVRILGIWGMGGIGKTTLASALYDKLSPEFEGCCFLANVRE 259
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPK-VESHFVTRRLRRKKVFIVLDDVATSEQLE 206
+S+K G LRNKLFS LLE ENL D + SHFV RL RKKVFIVLDDV TSEQLE
Sbjct: 260 ESDKHGFKALRNKLFSELLENENLCFDASSFLVSHFVLSRLGRKKVFIVLDDVDTSEQLE 319
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGY 26
LI D D LG GSRV+VTTR++ IFS VD IY+VKEL+ H SL+LFCL+ FR+ P++GY
Sbjct: 320 NLIEDFDFLGLGSRVIVTTRNKQIFSQVDKIYKVKELSIHHSLKLFCLSVFREKQPKHGY 379
Query: 25 EELSESAI 2
E+LS SAI
Sbjct: 380 EDLSRSAI 387
>KRG89808.1 hypothetical protein GLYMA_20G048800 [Glycine max] KRG89809.1
hypothetical protein GLYMA_20G048800 [Glycine max]
Length = 659
Score = 444 bits (1141), Expect = e-148
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>KYP39886.1 Putative disease resistance protein At4g11170 family [Cajanus cajan]
Length = 976
Score = 449 bits (1154), Expect = e-146
Identities = 238/367 (64%), Positives = 278/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVF+SFRGEDTR N TSHL+ AL QK++ETYIDY LEKGDEIS ALI AIE SH+S+
Sbjct: 19 KKYDVFISFRGEDTRKNFTSHLYEALKQKKIETYIDYHLEKGDEISTALIEAIENSHISI 78
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E++KI+ECKKE+GQ+V+PVFY +DPSHVRKQ G YE F +H+ +
Sbjct: 79 VIFSENYASSKWCLSELSKILECKKEKGQIVIPVFYNLDPSHVRKQTGSYEQAFGKHKGE 138
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
R KW+ ALTEAANL WDS YRTESE +KDIV D+L KL YP KGL
Sbjct: 139 -----PRCSKWKAALTEAANLVAWDS--QAYRTESELLKDIVDDVLGKLAPRYPNNHKGL 191
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGI ENY +ESLL+IGS EVR GKTTLA AL+ KLS +FEG CFL +VRE
Sbjct: 192 VGIGENYEKIESLLKIGSSEVRILGLWGMGGIGKTTLASALYDKLSHEFEGRCFLTNVRE 251
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+S+K GL LRNKLFS LLE + D+P + S FV RL RKKVFIVLDDVATSEQLE
Sbjct: 252 ESDKHGLKALRNKLFSELLEIKKPCFDVPFLVSDFVLSRLGRKKVFIVLDDVATSEQLEN 311
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GS+VVVTTR++ IFS VD IY+VKEL+ + S QLFCL SFR+ P++GYE
Sbjct: 312 LIEDFDFLGLGSKVVVTTRNKQIFSKVDKIYKVKELSFYHSFQLFCLTSFREKLPKHGYE 371
Query: 22 ELSESAI 2
++S SAI
Sbjct: 372 DVSRSAI 378
>KRG89798.1 hypothetical protein GLYMA_20G048800 [Glycine max] KRG89799.1
hypothetical protein GLYMA_20G048800 [Glycine max]
KRG89800.1 hypothetical protein GLYMA_20G048800 [Glycine
max]
Length = 888
Score = 444 bits (1141), Expect = e-145
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>XP_006605620.1 PREDICTED: TMV resistance protein N-like isoform X3 [Glycine max]
KRG89801.1 hypothetical protein GLYMA_20G048800 [Glycine
max] KRG89802.1 hypothetical protein GLYMA_20G048800
[Glycine max] KRG89803.1 hypothetical protein
GLYMA_20G048800 [Glycine max] KRG89804.1 hypothetical
protein GLYMA_20G048800 [Glycine max] KRG89805.1
hypothetical protein GLYMA_20G048800 [Glycine max]
KRG89806.1 hypothetical protein GLYMA_20G048800 [Glycine
max] KRG89807.1 hypothetical protein GLYMA_20G048800
[Glycine max]
Length = 895
Score = 444 bits (1141), Expect = e-145
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>XP_014519091.1 PREDICTED: TMV resistance protein N-like isoform X2 [Vigna radiata
var. radiata]
Length = 671
Score = 432 bits (1110), Expect = e-143
Identities = 232/366 (63%), Positives = 275/366 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
K+YDVFLSFRGEDTR TSHL+ AL QK+VET+ID RLEKG+EIS LI IE+SH+S+
Sbjct: 23 KRYDVFLSFRGEDTRKKFTSHLYDALKQKKVETFIDNRLEKGEEISTTLIQVIEDSHISI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VIFSENYASSKWCL E++KI+ECKKE+GQ+V+PVFY +DPSHVRKQ G YE F H+ +
Sbjct: 83 VIFSENYASSKWCLGELSKIMECKKEKGQIVIPVFYDIDPSHVRKQTGSYEKLFVTHKGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+KW+ ALTEAANLA WDS TYR ESE +KDIV+D+LQKL IYP KGL
Sbjct: 143 -----PMCNKWKAALTEAANLAAWDS--QTYRVESELLKDIVEDVLQKLAPIYPNCHKGL 195
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIEENY +ESLL++GS EV+ GKTTLA AL+ KLS +FEGHCFL +VRE
Sbjct: 196 VGIEENYEKIESLLKVGSNEVKILGIWGMGGIGKTTLARALYDKLSHEFEGHCFLENVRE 255
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+S+K G+ LRNKLFS LL +N D+ + FV RL RKKVFIVLDDVATSEQLE
Sbjct: 256 ESDKHGVKALRNKLFSELLGNKNHCFDVAFSVTKFVLSRLGRKKVFIVLDDVATSEQLEN 315
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D +G GSRVVVT+R++ IFS D IYEVKEL+ H SLQLF L FR+ P+ GYE
Sbjct: 316 LIEDFDFMGLGSRVVVTSRNKQIFSQ-DKIYEVKELSFHHSLQLFSLTVFREKQPKYGYE 374
Query: 22 ELSESA 5
+LS SA
Sbjct: 375 DLSRSA 380
>XP_006605619.1 PREDICTED: TMV resistance protein N-like isoform X2 [Glycine max]
KRG89793.1 hypothetical protein GLYMA_20G048800 [Glycine
max] KRG89794.1 hypothetical protein GLYMA_20G048800
[Glycine max] KRG89795.1 hypothetical protein
GLYMA_20G048800 [Glycine max] KRG89796.1 hypothetical
protein GLYMA_20G048800 [Glycine max]
Length = 1090
Score = 444 bits (1141), Expect = e-143
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>KRG89797.1 hypothetical protein GLYMA_20G048800 [Glycine max]
Length = 1114
Score = 444 bits (1141), Expect = e-143
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>XP_006605615.1 PREDICTED: TMV resistance protein N-like isoform X1 [Glycine max]
XP_006605616.1 PREDICTED: TMV resistance protein N-like
isoform X1 [Glycine max] XP_006605617.1 PREDICTED: TMV
resistance protein N-like isoform X1 [Glycine max]
XP_006605618.1 PREDICTED: TMV resistance protein N-like
isoform X1 [Glycine max] XP_014628480.1 PREDICTED: TMV
resistance protein N-like isoform X1 [Glycine max]
Length = 1121
Score = 444 bits (1141), Expect = e-143
Identities = 235/367 (64%), Positives = 276/367 (75%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYRLEKGDEISAALITAIEESHVSV 923
KKYDVFLSFRGEDTR N TSHLH AL QK+VETYIDY+LEKGDEIS ALI AIE+SHVS+
Sbjct: 23 KKYDVFLSFRGEDTRMNFTSHLHEALKQKKVETYIDYQLEKGDEISPALIKAIEDSHVSI 82
Query: 922 VIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQD 743
VI SENYASSKWCL+E++KI+ECKK++GQ+V+PVF+ +DPSHVRKQ G YE FA+HE +
Sbjct: 83 VILSENYASSKWCLEELSKILECKKKQGQIVIPVFHNIDPSHVRKQNGSYEKAFAKHEGE 142
Query: 742 LNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKGL 563
+ +KW+ LTE ANLAGWDS RTESE +KDIV D+L+KL YP +LKGL
Sbjct: 143 A-----KCNKWKATLTEVANLAGWDSRN---RTESELLKDIVGDVLRKLTPRYPNQLKGL 194
Query: 562 VGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVRE 383
VGIE+NY VESLL+IGS EV GKTTLA A +AKLS +FE CFL +VRE
Sbjct: 195 VGIEDNYEKVESLLKIGSSEVITLGIWGMGGIGKTTLASAFYAKLSHEFEADCFLVNVRE 254
Query: 382 QSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLEG 203
+++ GL L KLFS LLE EN D P + S FV RRL KKV IVLDDVATSEQLE
Sbjct: 255 NAKRHGLEALSQKLFSELLENENHCFDAPFLVSQFVMRRLGCKKVLIVLDDVATSEQLEY 314
Query: 202 LISDSDCLGPGSRVVVTTRDRHIFSHVDGIYEVKELNKHDSLQLFCLNSFRKMHPENGYE 23
LI D D LG GSRV+VTTR++ IF VD +YEVKEL+ H+SLQLFCL F + P +GYE
Sbjct: 315 LIKDYDLLGQGSRVIVTTRNKQIFRQVDEVYEVKELSFHNSLQLFCLTVFEEKQPTHGYE 374
Query: 22 ELSESAI 2
+LS AI
Sbjct: 375 DLSSRAI 381
>XP_013460028.1 disease resistance protein (TIR-NBS-LRR class) [Medicago truncatula]
KEH34059.1 disease resistance protein (TIR-NBS-LRR class)
[Medicago truncatula]
Length = 884
Score = 437 bits (1123), Expect = e-143
Identities = 231/370 (62%), Positives = 282/370 (76%), Gaps = 3/370 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYR-LEKGDEISAALITAIEESHVS 926
KKYDVFLSFRGEDTR N TSHL+ AL +K+VET+ID L KGDEISAALI AIEESH S
Sbjct: 17 KKYDVFLSFRGEDTRRNFTSHLYDALSRKKVETFIDNNELRKGDEISAALIKAIEESHAS 76
Query: 925 VVIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQ 746
+VIFSENYASSKWCL+E+ KI+ECKK Q+V+PVFY +DPSHVRKQ G Y+ FA+H+Q
Sbjct: 77 IVIFSENYASSKWCLNELKKILECKKYMQQIVIPVFYNIDPSHVRKQTGSYKQAFAKHKQ 136
Query: 745 DLNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKG 566
DL + ++ KW+ +LTEAANL GWDS YR+E +FIKDIV+D+L+KL++ YP E+KG
Sbjct: 137 DLKHNNDKLKKWKDSLTEAANLVGWDS--RNYRSEPDFIKDIVEDVLRKLNIRYPYEIKG 194
Query: 565 LVGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVR 386
LVGIE+NY +ES+L+IGS EVR GKTTLA L+AK SQFEG C L +V
Sbjct: 195 LVGIEKNYEQIESMLKIGSNEVRVLGIWGMGGIGKTTLAKTLYAKHFSQFEGRCVL-NVM 253
Query: 385 EQSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
++S K GLNVL NKL S+LLEEEN+H D +E+ F RR+ RKKV IVLD V T EQ+E
Sbjct: 254 DESNKYGLNVLHNKLLSSLLEEENIHPDASYIEAPFSERRIGRKKVLIVLDGVETLEQIE 313
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVD--GIYEVKELNKHDSLQLFCLNSFRKMHPEN 32
LI D LGPGSRV++TTRD+ IFS + IYEVKEL K DSLQLF L +F++ HP+
Sbjct: 314 DLILKIDGLGPGSRVIITTRDKQIFSQLSKCEIYEVKELEKPDSLQLFSLIAFKEKHPKT 373
Query: 31 GYEELSESAI 2
GYE+LS+S I
Sbjct: 374 GYEDLSDSVI 383
>XP_013460038.1 disease resistance protein (TIR-NBS-LRR class) [Medicago truncatula]
KEH34069.1 disease resistance protein (TIR-NBS-LRR class)
[Medicago truncatula]
Length = 1093
Score = 441 bits (1133), Expect = e-142
Identities = 230/370 (62%), Positives = 286/370 (77%), Gaps = 3/370 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYR-LEKGDEISAALITAIEESHVS 926
KKYD+FLSFRGEDTR N TSHL+ AL +K+VET+ID L+KGDEISAALI AIEESH S
Sbjct: 17 KKYDIFLSFRGEDTRRNFTSHLYDALSRKKVETFIDNNELQKGDEISAALIKAIEESHAS 76
Query: 925 VVIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQ 746
+VIFSENYASSKWCL+E+ KI+ECKK Q+V+PVFY +DPSHVRKQ G Y+ FA+H++
Sbjct: 77 IVIFSENYASSKWCLNELKKILECKKYMEQIVIPVFYNIDPSHVRKQTGSYKQAFAKHKR 136
Query: 745 DLNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKG 566
DL + ++ KW+ +LTEAANL GWDS YR+E +FIKDIV+D+L+KL+L YP E+KG
Sbjct: 137 DLKHNNDKLKKWKDSLTEAANLVGWDS--RNYRSEPDFIKDIVEDVLRKLNLRYPYEIKG 194
Query: 565 LVGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVR 386
LVGIE+NY +ES+L+IGS EVR GKTTLA AL+AK+ SQFEG C L +V
Sbjct: 195 LVGIEKNYKQIESMLKIGSHEVRVLGIWGMGGIGKTTLARALYAKMYSQFEG-CCLLNVM 253
Query: 385 EQSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
++S K GLNV+ NKL S+LLEEEN+H D +E+ F RR+ RKKV IVLD V T EQ+E
Sbjct: 254 DESNKYGLNVVLNKLLSSLLEEENIHPDASYIEAPFSERRIGRKKVLIVLDGVETLEQIE 313
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVD--GIYEVKELNKHDSLQLFCLNSFRKMHPEN 32
LI D LGPGSRV++TTRD+HIFS + IYEVKEL K DSLQLF L +F++ HP+
Sbjct: 314 DLIPKIDGLGPGSRVIITTRDKHIFSQLSKCEIYEVKELEKPDSLQLFSLTAFKEKHPKT 373
Query: 31 GYEELSESAI 2
GYE++S+S I
Sbjct: 374 GYEDVSDSVI 383
>XP_004516106.1 PREDICTED: TMV resistance protein N-like isoform X1 [Cicer arietinum]
XP_004516107.1 PREDICTED: TMV resistance protein N-like
isoform X1 [Cicer arietinum] XP_012567488.1 PREDICTED:
TMV resistance protein N-like isoform X1 [Cicer
arietinum]
Length = 1128
Score = 441 bits (1135), Expect = e-142
Identities = 231/370 (62%), Positives = 284/370 (76%), Gaps = 3/370 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYR-LEKGDEISAALITAIEESHVS 926
KKYDVFLSFRGEDTR N TSHL+ AL +K+VET+ID L+KGDEIS AL AIEESH S
Sbjct: 18 KKYDVFLSFRGEDTRRNFTSHLYDALSRKKVETFIDNNELKKGDEISPALAKAIEESHAS 77
Query: 925 VVIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQ 746
+VIFSENYASSKWCL+E+ KI+ECKK++ Q+V+PVFY +DPSHVRKQ G Y+ FA H++
Sbjct: 78 IVIFSENYASSKWCLNELKKILECKKDKEQIVIPVFYNIDPSHVRKQTGSYQKAFAEHKR 137
Query: 745 DLNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKG 566
DL + ++ KW+ ALTEAANL GWDS YR ES+FIKDIVKD+L++L+L YP E+KG
Sbjct: 138 DLMYNNDKLQKWKAALTEAANLVGWDS--QKYRIESDFIKDIVKDVLRQLNLRYPYEIKG 195
Query: 565 LVGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVR 386
+VGIE+NY +ES+L+IGS +VR GKTTLA AL++KL SQFEG CF+ +V
Sbjct: 196 VVGIEKNYEQIESMLKIGSNDVRVLGIWGMGGIGKTTLAKALYSKLCSQFEGRCFV-NVM 254
Query: 385 EQSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
++S+K GLNV+ N +S LLEEENLH D P +E+ F RR+ RKKVFIVLD V TSEQ+E
Sbjct: 255 DESKKYGLNVVHNNFYSTLLEEENLHHDAPYIEAPFSMRRIARKKVFIVLDGVETSEQIE 314
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVD--GIYEVKELNKHDSLQLFCLNSFRKMHPEN 32
LI D LG GSRV++TTR++HIFS IYEVKEL KHDSLQLF L F HP+
Sbjct: 315 DLILKIDELGVGSRVIITTRNKHIFSQFSKCEIYEVKELKKHDSLQLFNLTVFGDEHPKI 374
Query: 31 GYEELSESAI 2
GYE+LSES +
Sbjct: 375 GYEDLSESVV 384
>XP_013460039.1 disease resistance protein (TIR-NBS-LRR class) [Medicago truncatula]
KEH34070.1 disease resistance protein (TIR-NBS-LRR class)
[Medicago truncatula]
Length = 1097
Score = 441 bits (1133), Expect = e-142
Identities = 230/370 (62%), Positives = 286/370 (77%), Gaps = 3/370 (0%)
Frame = -2
Query: 1102 KKYDVFLSFRGEDTRGNITSHLHAALMQKRVETYIDYR-LEKGDEISAALITAIEESHVS 926
KKYD+FLSFRGEDTR N TSHL+ AL +K+VET+ID L+KGDEISAALI AIEESH S
Sbjct: 17 KKYDIFLSFRGEDTRRNFTSHLYDALSRKKVETFIDNNELQKGDEISAALIKAIEESHAS 76
Query: 925 VVIFSENYASSKWCLDEVAKIVECKKERGQVVVPVFYKVDPSHVRKQRGRYEVEFARHEQ 746
+VIFSENYASSKWCL+E+ KI+ECKK Q+V+PVFY +DPSHVRKQ G Y+ FA+H++
Sbjct: 77 IVIFSENYASSKWCLNELKKILECKKYMEQIVIPVFYNIDPSHVRKQTGSYKQAFAKHKR 136
Query: 745 DLNTDLHRVHKWRRALTEAANLAGWDSLTYTYRTESEFIKDIVKDILQKLDLIYPVELKG 566
DL + ++ KW+ +LTEAANL GWDS YR+E +FIKDIV+D+L+KL+L YP E+KG
Sbjct: 137 DLKHNNDKLKKWKDSLTEAANLVGWDS--RNYRSEPDFIKDIVEDVLRKLNLRYPYEIKG 194
Query: 565 LVGIEENYVGVESLLEIGSREVRXXXXXXXXXXGKTTLAIALHAKLSSQFEGHCFLASVR 386
LVGIE+NY +ES+L+IGS EVR GKTTLA AL+AK+ SQFEG C L +V
Sbjct: 195 LVGIEKNYKQIESMLKIGSHEVRVLGIWGMGGIGKTTLARALYAKMYSQFEG-CCLLNVM 253
Query: 385 EQSEKCGLNVLRNKLFSALLEEENLHVDIPKVESHFVTRRLRRKKVFIVLDDVATSEQLE 206
++S K GLNV+ NKL S+LLEEEN+H D +E+ F RR+ RKKV IVLD V T EQ+E
Sbjct: 254 DESNKYGLNVVLNKLLSSLLEEENIHPDASYIEAPFSERRIGRKKVLIVLDGVETLEQIE 313
Query: 205 GLISDSDCLGPGSRVVVTTRDRHIFSHVD--GIYEVKELNKHDSLQLFCLNSFRKMHPEN 32
LI D LGPGSRV++TTRD+HIFS + IYEVKEL K DSLQLF L +F++ HP+
Sbjct: 314 DLIPKIDGLGPGSRVIITTRDKHIFSQLSKCEIYEVKELEKPDSLQLFSLTAFKEKHPKT 373
Query: 31 GYEELSESAI 2
GYE++S+S I
Sbjct: 374 GYEDVSDSVI 383